Blake KV: Montelukast: data from clinical trials in the managementof asthma. Ann Pharmacother. 1999, 33: 1299-314. 10.1345/aph.18430.
Article
CAS
PubMed
Google Scholar
National Heart, Lung, and Blood Institute, National Asthma Education Program. Guidelines for the diagnosis and management of asthma. Expert Panel report II. 1997, Bethesda (MD):US Department of Health and Human Services, Pub. No.: 97-4051
Gotshall RW: Exercise-induced bronchoconstriction. Drugs. 2002, 62: 1725-39. 10.2165/00003495-200262120-00003.
Article
PubMed
Google Scholar
Marciniuk DD, Cockcroft DW: Exercise-induced bronchoconstriction:the role of leukotriene modifiers in therapy. Can J Allergy Clin Immun. 1998, 3: 298-303.
Google Scholar
Salvi SS, Krishna MT, Sampson AP, Holgate ST: The anti-inflammatory effects of leukotriene-modifying drugs and their use in asthma. Chest. 2001, 119: 1533-46. 10.1378/chest.119.5.1533.
Article
CAS
PubMed
Google Scholar
Drazen JM, Israel E, O'Byrne PM: Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med. 1999, 340: 197-206. 10.1056/NEJM199901213400306.
Article
CAS
PubMed
Google Scholar
Renzi PM: Antileukotriene agents in asthma: the dart that kills the elephant?. CMAJ. 1999, 160: 217-223.
PubMed Central
CAS
PubMed
Google Scholar
Vidal C, Fernandez-Ovide E, Pineiro J: Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction. Ann Allergy Asthma Immunol. 2001, 86: 655-8. 10.1016/S1081-1206(10)62294-6.
Article
CAS
PubMed
Google Scholar
American Thoracic Society: Guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med. 2000, 161: 309-29.
Article
Google Scholar
O'Byrne PM: Leukotriene bronchoconstriction induced by allergen and exercise. Am J Respir Crit Care Med. 2000, 161: S68-72.
Article
PubMed
Google Scholar
Tan RA, Spector SL: Clinical exercise testing. Edited by: Weisman IM, Zeballos RJ. 2002, Basel: Karger, 205-16.
Chapter
Google Scholar
Tan TA, Spector SL: Exercise-induced asthma: diagnosis and management. Ann Allergy Asthma Immunol. 2002, 89: 226-36. 10.1016/S1081-1206(10)61948-5.
Article
PubMed
Google Scholar
Inman MD, O'Byrne PM: The effect of regular inhaled albuterol on exercise-induced bronchoconstriction. Am J Respir Crit Care Med. 1996, 153: 65-9.
Article
CAS
PubMed
Google Scholar
Edelman JM, Turpin JA, Bronsky EA: Oral montelukast compared with inhaled salmeterol to prevent exercise-induced bronchoconstriction. Ann Intern Med. 2000, 132: 97-104.
Article
CAS
PubMed
Google Scholar
Jonasson G, Carlsen KH, Hultquis C: Low-dose budesonide improves exercise-induced bronchospasm in schoolchildren. Pediatr AllergyImmunol. 2000, 11: 120-5.
Article
CAS
Google Scholar
Thio BJ, Slingerland GL, Nagelkerke AF: Effects of single-dose fluticasone on exercise induced asthma in asthmatic children: a pilot study. Pediatr Pulmonol. 2001, 32: 115-21. 10.1002/ppul.1097.
Article
CAS
PubMed
Google Scholar
Takahashi N, Ishibashi Y, Murakami Y: Beneficial effect of combination therapy with ozagrel and pranlukast in exercise-induced asthma demonstrated by krypton-81 m ventilation scintigraphy-- a case report. Ann Acad Med Singapore. 2000, 29: 766-9.
CAS
PubMed
Google Scholar
Lehnigk B, Rabe KF, Dent G: Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise induced bronchoconstriction and urinary LTE4 in asthmatic patients. Eur Respir J. 1998, 11: 617-23.
CAS
PubMed
Google Scholar
Coreno A, Skowronski M, Kotaru C, McFadden ER: Comparative effects of long-acting {158}2- agonists, leukotriene receptor antagonists, and a 5-lipoxygenase inhibitor on exercise-induced asthma. J Allergy Clin Immunol. 2000, 106: 500-6. 10.1067/mai.2000.109425.
Article
CAS
PubMed
Google Scholar
Pearlman DS, Ostrom NK, Bronsky EA: The leukotriene D4-receptor antagonist zafirlukast attenuates exercise-induced bronchoconstriction in children. J Pediatr. 1999, 134: 273-9. 10.1016/S0022-3476(99)70449-X.
Article
CAS
PubMed
Google Scholar
Reiss TF, Hill JB, Harman E: Increased urinary excretion of LTE4 after exercise and attenuation of exercise-induced bronchospasm by montelukast, a cysteinyl leukotriene receptor antagonist. Thorax. 1997, 52: 1030-5. 10.1136/thx.52.12.1030.
Article
PubMed Central
CAS
PubMed
Google Scholar
Leff JA, Busse WW, Pearlman D: Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise induced bronchoconstriction. N Engl J Med. 1998, 16 (339): 147-52. 10.1056/NEJM199807163390302.
Article
Google Scholar
Villaran C, O'Neill SJ, Helbling A: Montelukast versus salmeterol in patients with asthma and exercise-induced bronchoconstriction. Montelukast/Salmeterol Exercise Study Group. J Allergy Clin Immunol. 1999, 104: 547-53. 10.1016/S0091-6749(99)70322-2.
Article
CAS
PubMed
Google Scholar